Citeline Podcasts

Topics in the latest “Pinkcast” include Keytruda’s approval and a look ahead to related PD-1 data anticipated at ESMO, plus how Pfizer is incorporating pharmacoeconomic data earlier in product development.

For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast

Topics in the latest “Pinkcast” include Keytruda’s approval and a look ahead to related PD-1 data anticipated at ESMO, plus how Pfizer is incorporating pharmacoeconomic data earlier in product development.

For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast

In this week's podcast from "The Silver Sheet", we receive tips from Jay Crowley, architect of the FDA's Unique Device Identification system (UDI).

For a free trial of "The Silver Sheet", go to: http://www.pharmamedtechbi.com/publications/the-silver-sheet/free-trial?elsca1=silversheet&elsca2=ss-podcast&utm_source=silversheet&utm_medium=ss-podcast%20

In this week's podcast from "The Silver Sheet", we receive tips from Jay Crowley, architect of the FDA's Unique Device Identification system (UDI).

For a free trial of "The Silver Sheet", go to: http://www.pharmamedtechbi.com/publications/the-silver-sheet/free-trial?elsca1=silversheet&elsca2=ss-podcast&utm_source=silversheet&utm_medium=ss-podcast%20

Corrective and preventive action, or CAPA, can be tricky for many device manufacturers to master. In this inaugural “Silver Sheet” podcast, Cap Uldriks – a compliance expert who spent 32 years in FDA’s device center – offers recommendations to ensure a healthy, smooth CAPA program.

For a free trial of "The Silver Sheet", go to: http://www.pharmamedtechbi.com/publications/the-silver-sheet/free-trial?elsca1=silversheet&elsca2=ss-podcast&utm_source=silversheet&utm_medium=ss-podcast%20

Corrective and preventive action, or CAPA, can be tricky for many device manufacturers to master. In this inaugural “Silver Sheet” podcast, Cap Uldriks – a compliance expert who spent 32 years in FDA’s device center – offers recommendations to ensure a healthy, smooth CAPA program.

For a free trial of "The Silver Sheet", go to: http://www.pharmamedtechbi.com/publications/the-silver-sheet/free-trial?elsca1=silversheet&elsca2=ss-podcast&utm_source=silversheet&utm_medium=ss-podcast%20

Corrective and preventive action, or CAPA, can be tricky for many device manufacturers to master. In this inaugural “Silver Sheet” podcast, Cap Uldriks – a compliance expert who spent 32 years in FDA’s device center – offers recommendations to ensure a healthy, smooth CAPA program.

For a free trial of "The Silver Sheet", go to: http://www.pharmamedtechbi.com/publications/the-silver-sheet/free-trial?elsca1=silversheet&elsca2=ss-podcast&utm_source=silversheet&utm_medium=ss-podcast%20

This week's hot topics include news on biosimilars and the pipeline for treating the Ebola virus. For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast

This week's hot topics include news on biosimilars and the pipeline for treating the Ebola virus. For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast

This week's hot topics include news on biosimilars and the pipeline for treating the Ebola virus. For a free trial of "The Pink Sheet", click here: http://www.pharmamedtechbi.com/publications/the-pink-sheet/free-trial?elsca1=pink&elsca2=pinkcast&utm_source=soundcloud&utm_medium=pinkcast